New monthly shot could help people with obesity shed pounds

NCT ID NCT07595549

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 4 times

Summary

This study tests a once-monthly injection called berobenatide to help adults with overweight or obesity lose weight. About 954 participants will receive either the drug or a placebo for 20 months. The goal is to see if the drug is safe and effective for weight loss, including in people with type 2 diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body Weight diabetes mellitus endocrine system disorder glucose metabolism disease metabolic disease Nutritional and Metabolic Diseases nutritional disorder Obesity obesity disorder overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY OVERWEIGHT OVERWEIGHT AND/OR OBESITY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aa Mrc Llc
RECRUITING

Flint, Michigan, 48504, United States
Albuquerque Clinical Trials, Inc.
RECRUITING

Albuquerque, New Mexico, 87102, United States
ClearVue Eye Care
RECRUITING

Roseville, California, 95661, United States
Clinical Trials Research
RECRUITING

Sacramento, California, 95821, United States
Diablo Clinical Research, Inc.
RECRUITING

Walnut Creek, California, 94598, United States
Fukuwa Clinic
NOT_YET_RECRUITING

Chuo-ku, Tokyo, 104-0031, Japan
ImmuniMet, LLC
RECRUITING

Modesto, California, 95350, United States
MediSphere Medical Research Center, LLC
RECRUITING

Evansville, Indiana, 47714, United States
Medical Corporation Heishinkai OCROM Clinic
NOT_YET_RECRUITING

Suita, Osaka, 565-0853, Japan
Medical Corporation Heishinkai ToCROM Clinic
NOT_YET_RECRUITING

Shinjuku-ku, Tokyo, 160-0008, Japan
Medication Management LLC
RECRUITING

Greensboro, North Carolina, 27405, United States
Midwest Eye Center
RECRUITING

Cincinnati, Ohio, 45202, United States
Monroe Biomedical Research
RECRUITING

Louisville, Kentucky, 40213, United States
Nature Coast Clinical Research
RECRUITING

Crystal River, Florida, 34429, United States
Rochester Clinical Research, LLC
RECRUITING

Rochester, New York, 14609, United States
South Broward Research
RECRUITING

Miramar, Florida, 33027, United States
Suncoast Clinical Research, Inc.
RECRUITING

New Port Richey, Florida, 34652, United States
Tokyo Center Clinic
NOT_YET_RECRUITING

Chuo-ku, Tokyo, 103-0027, Japan
Tokyo-Eki Center-Building Clinic
NOT_YET_RECRUITING

Chuo-ku, Tokyo, 103-0027, Japan
University Clinical Investigators, Inc.
NOT_YET_RECRUITING

Tustin, California, 92780, United States
VIP Trials
RECRUITING

San Antonio, Texas, 78230, United States
Velocity Clinical Research, Mt. Auburn
RECRUITING

Cincinnati, Ohio, 45219, United States
West Coast Eye Institute
RECRUITING

Lecanto, Florida, 34461, United States
West Coast Medical Associates
RECRUITING

New Port Richey, Florida, 34652, United States
York Clinical Research, LLC
NOT_YET_RECRUITING

Norfolk, Virginia, 23504, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.